PO Box 4066 Alice Springs NT 0871
P: +61 8 8951 4700
General Enquiries: remotephcmanuals@flinders.edu.au
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment
† = other strengths and forms available. Doses in brackets (mL, tab) only apply to forms and strengths listed. Doses (mL) rounded up to nearest 0.2ml unless this is more than 10% above recommended dose.
Pregnancy: B2 – safe to use
Breastfeed: Appears safe
Oculogyric crisis
IM or IV
Single dose
Dexamethasone†
Inj: 4mg/mL (1mL, 2mL)
Pregnancy: A – safe, but use lowest dose for shortest time
Breastfeed: Use alternative if available
IV or IM if no IV access
Single dose
Hydrocortisone
Inj: 50mg/mL
Pregnancy: A– safe, but use lowest dose for shortest time
Breastfeed: Safe to use, avoid high doses
4mg/
kg/dose
Ibuprofen
Susp: 20mg/mL
Tab: 200mg, 400mg
Pregnancy: C– avoid
Breastfeed: Safe to use
Levetiracetam
Inj#: 100mg/mL (5mL)
Pregnancy: B3 – get advice
Breastfeed: Caution
# Mix measured dose with 100mL normal saline or glucose 5%.
Give by IV infusion over 15 minutes (head injury), 5 minutes (fits)
IV or intraosseous
Loading dose
Oral
4 times a day (qid)
If child dose for weight is more than dose for age — use dose for age
Supp
4 times a day (qid)
Tranexamic acid
Inj*: 100mg/mL
(5mL, 10mL)
Pregnancy: B1 – safe after first trimester
Breastfeed: Appears safe
Control bleeding in trauma
IV infusion
Loading dose
Loading dose:
For Adults: Dilute 1g in 100mL of normal saline or 5% dextrose and infuse over 10 minutes.
For children: Inject undiluted over 10 minutes. Dilute with normal saline if necessary
Maintenance dose
Maintenance dose:
For Adults: Dilute 1g in 1,000mL of normal saline or 5% glucose and infuse over 8 hours.
For children: Dilute 500mg in 500mL of normal saline or 5% glucose to give 1mg/mL and infuse at
2mL/kg/hour over 8 hours (maximum dose 125mg per hour).
Inject undiluted over 10 minutes. Dilute with normal saline if necessary.
Valproate†
Inj#: 400mg
Pregnancy D - avoid if possible
Breastfeed: Appears safe
Pregnancy categories: 'Harm’ means to foetus. For more detail see AMH or Therapeutic Guidelines
Category A: Have been taken by large numbers of pregnant and fertile women without any known
harm
Category B1: Have been used in a limited number of pregnant and fertile women without any known
harm. Animal studies have not shown harm
Category B2: Women as for B1. Animal studies are less adequate, but no evidence of harm
Category B3: Women as for B1. Animal studies shown some evidence of harm, but not clear if this
is significant for humans
Category C: Have caused or are suspected of causing non–permanent harm
Category D: Have caused or are suspected of causing permanent harm. Category C and D medicines
are not always contraindicated for use in fertile women. The risks and benefits need
to be discussed
Category X: Drugs which have such a high risk of causing permanent damage to the foetus that they should not be used in pregnancy or when there is a possibility of pregnancy
Note: † = Other strengths available
For more information and details on giving medicines see AMH, Therapeutic Guidelines, Medicines Book, Australian Injectable Drugs Handbook
PO Box 4066 Alice Springs NT 0871
P: +61 8 8951 4700
General Enquiries: remotephcmanuals@flinders.edu.au